Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes: a cohort study

Andrea De Luca

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Limited treatment options have been available for people with HIV who have had virological failure of the three original classes of HIV antiretroviral drugs-so-called triple-class virological failure (TCVF). However, introduction of new drugs and drug classes might have improved outcomes. We aimed to assess trends in virological and clinical outcomes for individuals with TCVF in 2000-09.
Original languageEnglish
Pages (from-to)119-127
Number of pages9
JournalThe Lancet Infectious Diseases
Volume12
DOIs
Publication statusPublished - 2012

Keywords

  • Adolescent
  • Adult
  • Anti-HIV Agents
  • CD4 Lymphocyte Count
  • Cohort Studies
  • Female
  • HIV Infections
  • HIV-1
  • Humans
  • Male
  • Middle Aged
  • RNA, Viral
  • Regression Analysis
  • Retrospective Studies
  • Young Adult

Fingerprint

Dive into the research topics of 'Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes: a cohort study'. Together they form a unique fingerprint.

Cite this